학술논문
Investigation of tumefactive demyelination is associated with higher economic burden and more adverse events compared with conventional multiple sclerosis
Document Type
Article
Author
Source
In Multiple Sclerosis and Related Disorders October 2019 35:104-107
Subject
Language
ISSN
2211-0348